» Articles » PMID: 37833991

Mitogen-Activated Protein Kinase and Exploratory Nuclear Receptor Crosstalk in Cancer Immunotherapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Oct 14
PMID 37833991
Authors
Affiliations
Soon will be listed here.
Abstract

The three major mitogen-activated protein kinase (MAPK) pathways (ERK1/2, p38, and JNK/SAPK) are upstream regulators of the nuclear receptor superfamily (NRSF). These ligand-activated transcription factors are divided into subclasses comprising receptors for endocrine hormones, metabolic compounds (e.g., vitamins, diet), xenobiotics, and mediators released from host immune reactions such as tissue injury and inflammation. These internal and external cues place the NRSF at the frontline as sensors and translators of information from the environment towards the genome. For most of the former "orphan" receptors, physiological and synthetic ligands have been identified, opening intriguing opportunities for combination therapies with existing cancer medications. Hitherto, only preclinical data are available, warranting further validation in clinical trials in patients. The current review summarized the existing literature covering the expression and function of NRSF subclasses in human solid tumors and hematopoietic malignancies and their modulatory effects on innate (e.g., macrophages, dendritic cells) and adaptive (i.e., T cell subsets) immune cells, encouraging mechanistic and pharmacological studies in combination with current clinically approved therapeutics against immune checkpoint molecules (e.g., PD1).

Citing Articles

Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling.

Ding B, Li J, Yan J, Jiang C, Qian L, Pan J Front Immunol. 2025; 16:1515605.

PMID: 39963142 PMC: 11830804. DOI: 10.3389/fimmu.2025.1515605.


Special Issue: MAPK Signaling Cascades in Human Health and Diseases.

Seger R Int J Mol Sci. 2024; 25(20).

PMID: 39457006 PMC: 11509016. DOI: 10.3390/ijms252011226.


Network pharmacology-based research on the effect of Radix Astragali on osteosarcoma and the underlying mechanism.

Zhang Y, Wei J, Kong L, Song M, Zhang Y, Xiao X Sci Rep. 2023; 13(1):22315.

PMID: 38102307 PMC: 10724296. DOI: 10.1038/s41598-023-49597-x.

References
1.
Abdel-Gadir A, Stephen-Victor E, Gerber G, Noval Rivas M, Wang S, Harb H . Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy. Nat Med. 2019; 25(7):1164-1174. PMC: 6677395. DOI: 10.1038/s41591-019-0461-z. View

2.
Lausen J, Thomas H, Lemm I, Bulman M, Borgschulze M, Lingott A . Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res. 1999; 28(2):430-7. PMC: 102517. DOI: 10.1093/nar/28.2.430. View

3.
Maczewsky J, Kaiser J, Krippeit-Drews P, Drews G . Approved LXR agonists exert unspecific effects on pancreatic β-cell function. Endocrine. 2020; 68(3):526-535. PMC: 7308254. DOI: 10.1007/s12020-020-02241-4. View

4.
Sarkar A, Carter E, Harland J, Speelman A, Lehnert N, Ragsdale S . Ferric heme as a CO/NO sensor in the nuclear receptor Rev-Erbß by coupling gas binding to electron transfer. Proc Natl Acad Sci U S A. 2021; 118(3). PMC: 7826342. DOI: 10.1073/pnas.2016717118. View

5.
Dierickx P, Emmett M, Jiang C, Uehara K, Liu M, Adlanmerini M . SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. Proc Natl Acad Sci U S A. 2019; 116(25):12147-12152. PMC: 6589768. DOI: 10.1073/pnas.1904226116. View